Gotte Alisa Carman
University of Texas Southwestern Medical Center, Department of Pediatrics, Dallas, TX, USA.
Open Access Rheumatol. 2009 May 14;1:37-49. doi: 10.2147/oarrr.s5103. eCollection 2009.
Intra-articular corticosteroid injection (IACI) has been used in the treatment of inflammatory arthritis in adults for over fifty years. Over the last two decades, IACI has become an important tool in the management of juvenile idiopathic arthritis (JIA), particularly in the oligoarthritis subset of JIA. Many factors may affect the efficacy of this treatment modality, although the majority of evidence on this topic is anecdotal, nonconvincing, or conflicting. The review examines the rationale, efficacy, safety, and application of the use of IACI in the treatment of JIA, focusing on factors that affect the outcome following IACI.
关节内注射皮质类固醇(IACI)已用于治疗成人炎性关节炎五十多年。在过去二十年中,IACI已成为治疗幼年特发性关节炎(JIA)的重要工具,尤其是在JIA的少关节炎亚型中。许多因素可能影响这种治疗方式的疗效,尽管关于这一主题的大多数证据都是轶事性的、缺乏说服力的或相互矛盾的。本综述探讨了IACI在治疗JIA中的基本原理、疗效、安全性及应用,重点关注影响IACI治疗效果的因素。